National Institutes of Health Clinical Center Hazardous Drug List
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (gen er ic names app ear in bold- fac ed type) (gener ic names app ear in bold- fac ed type)
2-CdA AKA cladribine AKA ethiofos, ethiophos, Ethyol®, amifostine WR2721 5-FU AKA fluorouracil Anandron® AKA nilutamide 8-MOP® AKA methoxsalen anastrozole AKA Arimidex® abacavir sulfate AKA Ziagen® ANCOBON® AKA flucytosine abiraterone acetate AKA Zytiga® ARA-A AKA vidarabine AKA paclitaxel protein-bound particles Abraxane™ for injectable suspension ARA-C AKA cytarabine actinomycin D AKA dactinomycin Arranon® AKA nelarabine ADCETRIS® AKA brentuximab vedotin Arimidex® AKA anastrozole ado-trastuzumab emtansine AKA KADCYLA™ AROMASIN® AKA exemestane Adriamycin PFS® AKA doxorubicin HCl arsenic trioxide AKA Trisenox® Adriamycin RDF® AKA doxorubicin HCl asparaginase AKA L-asparaginase, Elspar®, Adrucil® AKA fluorouracil atezolizumab AKA TECENTRIQ® afatinib dimaleate AKA GILOTRIF® AVASTIN® AKA bevacizumab Afinitor® AKA everolimus azacitidine AKA Vidaza™ alemtuzumab AKA Campath®, Campath-1H Azasan® AKA azathioprine Alferon N® AKA interferon alfa-n3 azathioprine AKA Imuran®, Azasan® Alimta® AKA pemetrexed Bacillus Calmette Guerin AKA BCG Alkeran® AKA melphalan BCG AKA TheraCys®, TICE® BCG altretamine AKA Hexalen®, hexamethylmelamine BCNU AKA carmustine ALUNBRIG™ AKA brigatinib BELEODAQ® AKA belinostat ambrisentan AKA LETAIRIS® belinostat AKA BELEODAQ® amethopterin AKA methotrexate bendamustine hydrochloride AKA TREANDA® bevacizumab AKA AVASTIN®
Revised: March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 2
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (gen er ic names appe ar in bol d-faced type) (gener ic names app ear in bold- fac ed type)
bexarotene AKA Targretin® carfilzomib AKA KYPROLIS™ bicalutamide AKA Casodex® carmustine AKA BCNU, BiCNU® BiCNU® AKA carmustine AKA BCNU wafer, Gliadel® carmustine wafer implantable wafer Blenoxane® AKA bleomycin sulfate Casodex® AKA bicalutamide bleomycin sulfate AKA Blenoxane® caspofungin acetate AKA Cancidas® bortezomib AKA Velcade® CCNU AKA lomustine bosentan AKA Tracleer® CdA AKA cladribine BOSULIF® AKA bosutinib CeeNU® AKA lomustine bosutinib AKA BOSULIF® CellCept® AKA mycophenolate mofetil brentuximab vedotin AKA ADCETRIS® Cerubidine® AKA daunorubicin HCl brigatinib AKA ALUNBRIG™ chlorambucil AKA Leukeran® busulfan AKA Busulfex®, Myleran® chloramphenicol AKA Chloromycetin® Busulfex® AKA busulfan injection Chloromycetin® AKA chloramphenicol cabazitaxel AKA JEVTANA® cidofovir AKA Vistide® cabozantinib AKA CABOMETYX™, COMETRIQ® cisplatin AKA Platinol®, Platinol-AQ® CABOMETYX™ AKA cabozantinib cladribine AKA 2-CdA, CdA, Leustatin® Caelyx® AKA doxorubicin HCl, liposomal clofarabine AKA Clolar™ Campath® AKA alemtuzumab Clolar™ AKA clofarabine Campath-1H AKA alemtuzumab COMETRIQ® AKA cabozantinib Camptosar® AKA irinotecan HCl Cosmegen® AKA dactinomycin Cancidas® AKA caspofungin acetate CRESEMBA® AKA isavuconazonium sulfate capecitabine AKA Xeloda® crizotinib AKA XALKORI® CAPRELSA® AKA vandetanib cyclophosphamide AKA Cytoxan®, Neosar® carboplatin AKA Paraplatin®
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 3
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (gen er ic names appe ar in bol d-faced type) (gener ic names app ear in bold- fac ed type)
cytarabine AKA Ara-C. Cytosar-U®, Depo-Cyt® desflurane AKA Suprane® AKA ICRF-187, Zinecard® cytarabine liposome injection AKA Depo-Cyt® dexrazoxane hydrochloride for intrathecal use diethylstilbestrol AKA DES, Stilphostrol® Cytosar-U® AKA cytarabine docetaxel AKA Taxotere® Cytovene® AKA ganciclovir Doxil® AKA doxorubicin HCl, liposomal Cytoxan® AKA cyclophosphamide doxorubicin HCl, liposomal AKA Doxil®, liposomal doxorubicin dabrafenib AKA TAFINLAR® AKA Adriamycin, Adriamycin PFS®, dacarbazine AKA DTIC, DTIC-Dome® doxorubicin hydrochloride Adriamycin RDF®, Caelyx®, Doxil®, Rubex® Dacogen™ AKA decitabine Droxia® AKA hydroxyurea dactinomycin AKA actinomycin-D, Cosmegen® DTIC AKA dacarbazine dasatinib AKA Sprycel® DTIC-Dome® AKA dacarbazine daunomycin AKA daunorubicin Eldisine® AKA vindesine daunorubicin citrate, AKA DaunoXome®, liposomal Ellence® AKA epirubicin hydrochloride liposomal daunorubicin AKA EMPLICITI™ daunorubicin hydrochloride AKA Cerubidine® elotuzumab Eloxatin™ AKA oxaliplatin daunorubicin and cytarabine AKA VYXEOS® liposome for injection Elspar® AKA asparaginase DaunoXome® AKA daunorubicin citrate, liposomal Emcyt® AKA estramustine phosphate sodium decitabine AKA Dacogen™ EMPLICITI™ AKA elotuzumab degarelix AKA FIRMAGON® enasidenib AKA IDHIFA® deoxycoformycin AKA pentostatin enflurane AKA Ethrane® AKA cytarabine liposome injection for AKA XTANDI® Depo-Cyt® enzalutamide intrathecal use epirubicin hydrochloride AKA Ellence® Depo-Provera® AKA medroxyprogesterone acetate eribulin mesylate AKA HALAVEN™ DES AKA diethylstilbestrol, Stilphostrol®
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 4
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (gen er ic names appe ar in bol d-faced type) (gener ic names app ear in bold- fac ed type)
ERIVEDGE® AKA vismodegib floxuridine AKA FUDR® erlotinib AKA TARCEVA® flucytosine AKA ANCOBON® estradiol (many formulations) many branded & generic products fludarabine phosphate AKA Fludara® Estradurin® AKA polyoestradiol phosphate Fludara® AKA fludarabine phosphate AKA 5FU, 5-FU, Adrucil® estramustine phosphate AKA Emcyt® fluorouracil sodium flutamide AKA Euflex®, Eulexin® ethiofos AKA amifostine Folex® AKA methotrexate ethiophos AKA amifostine Folex® PFS AKA methotrexate Ethrane® AKA enflurane FOLOTYN® AKA pralatrexate Ethyol® AKA amifostine Forane® AKA isoflurane AKA VePesid®, Toposar®, VP-16, etoposide VP-16-213 FUDR® AKA floxuridine etoposide phosphate AKA Etopophos® fulvestrant AKA FASLODEX® Etopophos® AKA etoposide phosphate ganciclovir AKA Cytovene® Euflex® AKA flutamide gemcitabine hydrochloride AKA Gemzar® Eulexin® AKA flutamide gemtuzumab ozogamicin AKA Mylotarg™ everolimus AKA Afinitor®, Zortress® Gemzar® AKA gemcitabine hydrochloride exemestane AKA AROMASIN® GILOTRIF® AKA afatinib dimaleate Fareston® AKA toremifene citrate Gleevec® AKA imatinib mesylate FARYDAK® AKA panobinostat Gliadel® implantable wafer AKA carmustine wafer FASLODEX® AKA fulvestrant goserelin acetate AKA Zoladex® Femara® AKA letrozole HALAVEN™ AKA eribulin mesylate FK506 AKA tacrolimus halothane finasteride AKA Propecia®, Proscar® Hexalen® AKA altretamine FIRMAGON® AKA degarelix hexamethylmelamine AKA altretamine
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 5
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (gen er ic names appe ar in bol d-faced type) (gener ic names app ear in bold- fac ed type)
AKA topotecan HCl & topotecan, AKA Forane® Hycamtin® for Injection & capsules isoflurane respectively Istodax® AKA romidepsin Hydrea® AKA hydroxyurea ixabepilone AKA Ixempra™ hydroxyurea AKA Droxia®, Hydrea® ixazomib AKA NINLARO® ICLUSIG® AKA ponatinib IXEMPRA™ AKA ixabepilone ICRF-187 AKA dexrazoxane hydrochloride JAKAFI™ AKA ruxolitinib Idamycin® AKA idarubicin HCl JEVTANA® AKA cabazitaxel Idamycin PFS™ AKA idarubicin HCl KADCYLA™ AKA ado-trastuzumab emtansine idarubicin hydrochloride AKA Idamycin®, Idamycin PFS™ KEYTRUDA® AKA pembrolizumab IDHIFA® AKA enasidenib KYPROLIS™ AKA carfilzomib Ifex® AKA ifosfamide L-asparaginase AKA asparaginase ifosfamide AKA Ifex® L-PAM AKA melphalan imatinib mesylate AKA Gleevec® lapatinib ditosylate AKA TYKERB® Imuran® AKA azathioprine lenalidomide AKA Revlimid® INOmax® AKA nitric oxide for inhalation LETAIRIS™ AKA ambrisentan interferon alfa-2a AKA Roferon-A® letrozole AKA Femara® interferon alfa-2b AKA Intron A® Leukeran® AKA chlorambucil interferon alfa-2b, AKA Rebetron® AKA Lupron® recombinant + ribavirin leuprolide acetate Leustatin® AKA cladribine interferon alfa-n3 AKA Alferon N® lomustine AKA CCNU, CeeNU® interferon alfa-n1, AKA Wellferon® lymphoblastoid Lonsurf® AKA trifluridine + tipiracil Intron A® AKA interferon alfa-2b Lupron® AKA leuprolide acetate irinotecan hydrochloride AKA Camptosar® Lysodren® AKA mitotane isavuconazonium sulfate AKA CRESEMBA® macitentan AKA OPSUMIT®
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 6
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (gen er ic names appe ar in bol d-faced type) (gener ic names app ear in bold- fac ed type)
Matulane® AKA procarbazine Mustargen® AKA mechlorethamine
AKA HN2, Mustargen®, nitrogen Mutamycin® AKA mitomycin mechlorethamine mustard mycophenolate mofetil AKA CellCept® medroxyprogesterone AKA Depo-Provera®, Provera® mycophenolate sodium AKA Myfortic® Megace® AKA megestrol acetate Myfortic® AKA mycophenolate sodium megestrol acetate AKA Megace® Myleran® AKA busulfan MEKINIST® AKA trametinib dimethyl sulfoxide Mylotarg™ AKA gemtuzumab ozogamicin AKA Alkeran®, L-PAM, phenylalanine melphalan mustard Navelbine® AKA vinorelbine tartrate Nebupent® AKA pentamidine isethionate mercaptopurine AKA Purinethol®, PURIXAN™ Metastron® AKA strontium-89 chloride nelarabine AKA Arranon® AKA amethopterin, Folex PFS®, Neosar® AKA cyclophosphamide methotrexate methotrexate LPF®, Mexate®, Neutrexin® AKA trimetrexate glucuronate Rheumatrex® Nexavar® AKA sorafenib tosylate Methotrexate LPF® AKA methotrexate Nilandron® AKA nilutamide AKA UVADEX®, 8-MOP®, methoxsalen Methoxsalen-Rapid, Oxsoralen® nilotinib AKA TASIGNA® Lotion, OXSORELEN-ULTRA® nilutamide AKA Anandron®, Nilandron® Mexate® AKA methotrexate NINLARO® AKA ixazomib midostaurin AKA RYDAPT® Nipent® AKA pentostatin Mithracin® AKA plicamycin nitric oxide for inhalation AKA INOmax® mithramycin AKA plicamycin nitrogen mustard AKA mechlorethamine mitomycin AKA Mutamycin® nitrous oxide mitotane AKA Lysodren® nivolumab AKA OPDIVO® mitoxantrone hydrochloride AKA Novantrone® Nolvadex® AKA tamoxifen Mozobil® AKA plerixafor Novantrone® AKA mitoxantrone HCl
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 7
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (gen er ic names appe ar in bol d-faced type) (gener ic names app ear in bold- fac ed type)
NOXAFIL® AKA posaconazole phenylalanine mustard AKA melphalan omacetaxine mepesuccinate AKA SYNRIBO® Photofrin® AKA porfimer sodium Oncaspar® AKA pegaspargase Platinol-AQ® AKA cisplatin Oncovin® AKA vincristine sulfate Platinol® AKA cisplatin OPDIVO® AKA nivolumab plerixafor AKA Mozobil® OPSUMIT® AKA macitentan plicamycin AKA Mithracin®, mithramycin osimertinib mesylate AKA TAGRISSO™ polyoestradiol [sic] phosphate AKA Estradurin® oxaliplatin AKA Eloxatin® pomalidomide AKA POMALYST® Oxsoralen® Lotion, OXSORALEN- AKA methoxsalen POMALYST® AKA pomalidomde ULTRA® Capsules ponatinib AKA ICLUSIG® paclitaxel AKA Onxol®, Taxol® porfimer sodium AKA Photofrin® paclitaxel protein-bound particles for injectable AKA Abraxane™ posaconazole AKA NOXAFIL® suspension potassium hydroxide 15% panobinostat AKA FARYDAK® solution (for topical use) Paraplatin® AKA carboplatin pralatrexate AKA FOLOTYN® pazopanib hydrochloride AKA Votrient® procarbazine AKA Matulane® pegaspargase AKA Oncaspar® Prograf® AKA tacrolimus pembrolizumab AKA KEYTRUDA® Propecia® AKA finasteride Proscar® AKA finasteride pemetrexed AKA Alimta® Protopic® AKA tacrolimus Pentam® AKA pentamidine isethionate Provera® AKA medroxyprogesterone pentamidine isethionate AKA Pentam® 300, Nebupent® Purinethol® AKA mercaptopurine pentostatin AKA deoxycoformycin, Nipent® PURIXAN™ AKA mercaptopurine PERJETA™ AKA pertuzumab Quadramet® AKA samarium 153 lexidronam pertuzumab AKA PERJETA™
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 8
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (generic names appear in bold-faced type) (generic names appear in bold-faced type)
raltitrexed AKA Tomudex® streptozotocin AKA streptozocin RAPAMUNE® AKA sirolimus strontium-89 chloride AKA Metastron® AKA interferon alfa-2b, recombinant + AKA Sutent® Rebetron® sunitinib ribavirin Suprane® AKA desflurane regorafenib AKA STIVARGA® Sutent® AKA sunitinib Retrovir® AKA zidovudine SYNRIBO® AKA omacetaxine mepesuccinate Revlimid® AKA lenalidomide Tabloid® AKA thioguanine Rheumatrex® AKA methotrexate tacrolimus AKA FK506, Prograf®, Protopic® ribavirin AKA Virazole® TAFINLAR® AKA dabrafenib Roferon-A® AKA interferon alfa-2a TAGRISSO™ AKA osimertinib mesylate romidepsin AKA Istodax® talc powder, sterile AKA Sclerosol® Rubex® AKA doxorubicin HCl tamoxifen AKA Nolvadex® ruxolitinib AKA JAKAFI™ TARCEVA® AKA erlotinib RYDAPT® AKA midostaurin Targretin® AKA bexarotene SAHA AKA vorinostat TASIGNA® AKA nilotinib AKA Quadramet® samarium 153 lexidronam Taxol® AKA paclitaxel Sclerosol® Intrapleural Aerosol AKA talc powder, sterile Taxotere® AKA docetaxel AKA ® sirolimus RAPAMUNE TECENTRIQ® AKA atezolizumab SIVEXTRO® AKA tedizolid, tedizolid phosphate tedizolid AKA SIVEXTRO® sorafenib tosylate AKA Nexavar® tedizolid phosphate AKA SIVEXTRO® (injectable) Sprycel® AKA dasatinib Temodar® AKA temozolomide Stilphostrol® AKA diethylstilbestrol temozolomide AKA Temodar® STIVARGA® AKA regorafenib temsirolimus AKA TORISEL® streptozocin AKA Zanosar® teniposide AKA VM-26, Vumon®
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 9
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (gen er ic names appe ar in bol d-faced type) (gener ic names app ear in bold- fac ed type)
thalidomide AKA Thalomid® Trisenox™ AKA arsenic trioxide injection Thalomid® AKA thalidomide TYKERB® AKA lapatinib ditosylate TheraCys® AKA BCG UVADEX® AKA methoxsalen thioguanine AKA 6-TG, TG, Tabloid® Valcyte™ AKA valganciclovir hydrochloride Thioplex® AKA thiotepa valganciclovir hydrochloride AKA Valcyte™ AKA Thioplex® thiotepa valrubicin solution for AKA Valstar® intravesical instillation TICE BCG® AKA BCG AKA valrubicin solution for intravesical Valstar® Tomudex® AKA raltitrexed instillation topotecan AKA Hycamtin® capsules vandetanib AKA CAPRELSA® topotecan hydrochloride AKA Hycamtin® for injection Velban® AKA vinblastine sulfate toremifene citrate AKA Fareston® Velcade® AKA bortezomib TORISEL® AKA temsirolimus vemurafenib AKA ZELBORAF® trabectedin AKA YONDELIS® VENCLEXTA™ AKA venetoclax Tracleer® AKA bosentan venetoclax AKA VENCLEXTA™ trametinib dimethyl sulfoxide AKA MEKINIST® VePesid® AKA etoposide see: ado-trastuzumab emtansine; verteporfin AKA Visudyne® trastuzumab, ado- AKA, KADCYLA™ Vesanoid® AKA tretinoin TREANDA® AKA bendamustine HCl for injection vidarabine AKA ARA-A, Vira-A® TRELSTAR® AKA triptorelin Vidaza™ AKA azacitidine tretinoin AKA Vesanoid® vinblastine sulfate AKA Velban® trichloroacetic acid Vincasar® AKA vincristine trifluridine + tipiracil AKA LONSURF® vincristine sulfate AKA Oncovin®, Vincasar PFS® trimetrexate glucuronate AKA Neutrexin® vindesine AKA Eldisine® triptorelin AKA TRELSTAR®
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/ National Institutes of Health Clinical Center HAZARDOUS DRUG LIST page 10
Alphabetical Index Cross-Referenced Names Alphabetical Index Cross-Referenced Names (generic names appear in bold-faced type) (generic names appear in bold-faced type)
vinorelbine tartrate AKA Navelbine® zidovudine AKA AZT, Retrovir® Vira-A® AKA vidarabine Zinecard® AKA dexrazoxane hydrochloride Virazole® capsules AKA ribavirin ziv-aflibercept AKA ZALTRAP® Virazole® for inhalation solution AKA ribavirin Zoladex® AKA goserelin acetate vismodegib AKA ERIVEDGE® Zolinza® AKA vorinostat Vistide® AKA cidofovir zonisamide AKA Zonegran® Visudyne® AKA verteporfin Zonegran® AKA zonisamide VM-26 AKA teniposide Zortress® AKA everolimus vorinostat AKA Zolinza® Zytiga® AKA abiraterone acetate Votrient® AKA pazopanib hydrochloride VP-16 AKA etoposide Vumon® AKA teniposide AKA daunorubicin and cytarabine VYXEOS™ liposome for injection AKA interferon alfa-n1, Wellferon® lymphoblastoid WR2721 AKA amifostine XALKORI® AKA crizotinib Xeloda® AKA capecitabine XTANDI® AKA enzalutamide YONDELIS® AKA trabectedin ZALTRAP® AKA ziv-aflibercept Zanosar® AKA streptozocin ZELBORAF® AKA vemurafenib Ziagen® AKA abacavir
Revised March 26, 2018 The latest revision may be accessed at the Pharmacy Department’s Formulary & Drug Information website at http://intranet.cc.nih.gov/pharm/formulary/